Free Newsletter
Merck readies Tredaptive for int'l assault
Free newsletter via e-mail
Tools
Merck is prepping for the international launch of its cholesterol remedy Tredaptive later this year, with plans to market the drug in Mexico, the U.K. and Germany by the third quarter. Merck release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: